• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Clinical advice from the latest ARMOR study update

Article

In the most recent update from the ARMOR study, Penny Asbell, MD, FACS, MBA, explained that clinicians must choose their antibiotics carefully.

In the most recent update from the ARMOR study, Penny Asbell, MD, FACS, MBA, explained that clinicians must choose their antibiotics carefully. “Use the information that is available,” Dr. Asbell encouraged, adding that the ARMOR study offers up-to-date information on resistance patterns so clinicians will understand which antibiotics work most effectively.

 

 

Related articles: 

How to determine the proper dosage for intracameral moxifloxacin

Prompt attention vital to managing severe corneal infections

Why infections related to PK require intense vigilance

Gauging ganciclovir gel for herpes virus

Fungal infections after keratoplasty on upswing

Related Videos
Dissecting ARMOR study data on antibiotic resistance in ophthalmology
© 2024 MJH Life Sciences

All rights reserved.